evaluating Actimmune

Related by string. * EVALUATING . EVALUATED . Evaluated . evaluated . Evaluating : evaluating CK # . When evaluating Antigenics . rigorously evaluated . Intervention Trial Evaluating . evaluating OGX . prospectively evaluated . evaluating Nexavar . evaluating ispinesib . evaluating pirfenidone / : concerning Actimmune . prescribe Actimmune . Actimmune . Actimmune R . Actimmune ® * *

Related by context. Frequent words. (Click for all words.) 71 refractory chronic lymphocytic 69 forodesine 68 Phase Ib II 68 R sorafenib tablets 67 MKC# 67 phase IIb clinical 67 sunitinib malate 67 phase IIa clinical 67 elotuzumab 66 Initiate Phase 66 Ixempra 66 metastatic castration resistant 65 Pivotal Phase III 65 plus prednisone 65 metastatic hormone refractory 65 Phase Ib clinical 65 multicenter Phase 65 Panzem R 65 Daclizumab 65 Initiates Phase II 64 CALGB 64 randomized Phase III 64 PEG SN# 64 Gemzar ® 64 custirsen 64 APTIVUS 64 pertuzumab 64 phase Ib 64 ongoing Phase 1b 64 irbesartan 64 Fibrillex TM 64 CoFactor 64 Traficet EN 64 HER2 positive metastatic breast 64 phase IIb 64 Azedra 64 Pivotal Phase 64 relapsed refractory multiple myeloma 63 deforolimus 63 IIa trial 63 pulmonology portfolio 63 CIMZIA TM 63 phase IIa 63 confirmatory Phase III 63 liposomal formulation 63 Phase IIb trials 63 LymphoStat B 63 YERVOY 63 IMC #B 63 TELCYTA 63 tanespimycin 63 Vandetanib 63 Actimmune R 63 teriflunomide 63 Taxotere ® 63 ixabepilone 62 Rebif ® 62 Randomized controlled 62 registrational trial 62 Clonicel 62 placebo controlled clinical 62 temsirolimus 62 relapsing multiple sclerosis 62 pseudobulbar affect PBA 62 J Am Acad 62 PROMACTA 62 peginterferon alfa 2b 62 Tesetaxel 62 AVADO 62 EDEMA4 62 ThermoDox R 62 Phase 2a trial 62 atacicept 62 dacetuzumab 62 active comparator 62 II Clinical Trial 62 HGS ETR1 62 goserelin 62 placebo controlled Phase 62 subcutaneous formulation 62 senicapoc 62 plus dexamethasone 62 Phase 1b trial 62 INCB# [001] 62 NCCTG 62 TELINTRA 62 nab paclitaxel 62 Bicifadine 62 MYDICAR 61 Epratuzumab 61 Nanobody 61 axitinib 61 ATTRACT 61 GRNVAC1 61 KRN# 61 Phase 2a clinical 61 Laquinimod 61 sodium Injection 61 TYKERB 61 ocrelizumab 61 EndoTAG TM -1

Back to home page